OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets
Benjamin A. Weinberg, Joanne Xiu, Michael Lindberg, et al.
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 4, pp. 652-662
Open Access | Times Cited: 152
Benjamin A. Weinberg, Joanne Xiu, Michael Lindberg, et al.
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 4, pp. 652-662
Open Access | Times Cited: 152
Showing 26-50 of 152 citing articles:
Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications
Hendrien Kuipers, Tessa J. J. de Bitter, Marieke T. de Boer, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5257-5257
Open Access | Times Cited: 37
Hendrien Kuipers, Tessa J. J. de Bitter, Marieke T. de Boer, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5257-5257
Open Access | Times Cited: 37
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities
Xiangyu Wang, Wenwei Zhu, Zheng Wang, et al.
Theranostics (2021) Vol. 12, Iss. 1, pp. 260-276
Open Access | Times Cited: 37
Xiangyu Wang, Wenwei Zhu, Zheng Wang, et al.
Theranostics (2021) Vol. 12, Iss. 1, pp. 260-276
Open Access | Times Cited: 37
Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing
Szilvia Lilla Csoma, Judit Bedekovics, G. Veres, et al.
Cancers (2022) Vol. 14, Iss. 1, pp. 233-233
Open Access | Times Cited: 25
Szilvia Lilla Csoma, Judit Bedekovics, G. Veres, et al.
Cancers (2022) Vol. 14, Iss. 1, pp. 233-233
Open Access | Times Cited: 25
A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer
Muhammet Özer, Suleyman Yasin Goksu, Nina N. Sanford, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2146912-e2146912
Open Access | Times Cited: 25
Muhammet Özer, Suleyman Yasin Goksu, Nina N. Sanford, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2146912-e2146912
Open Access | Times Cited: 25
Role of molecular genetics in the clinical management of cholangiocarcinoma
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 25
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 25
Biomarkers for response to immunotherapy in hepatobiliary malignancies
Zhifei Lin, Lun‐Xiu Qin, Jinhong Chen
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 413-419
Closed Access | Times Cited: 23
Zhifei Lin, Lun‐Xiu Qin, Jinhong Chen
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 413-419
Closed Access | Times Cited: 23
Molecular Profile of Intrahepatic Cholangiocarcinoma
Wellington Andraus, Francisco Tustumi, José Donizeti de Meira Júnior, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 461-461
Open Access | Times Cited: 15
Wellington Andraus, Francisco Tustumi, José Donizeti de Meira Júnior, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 461-461
Open Access | Times Cited: 15
SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, et al.
Cancer (2024) Vol. 130, Iss. 17, pp. 2918-2927
Closed Access | Times Cited: 6
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, et al.
Cancer (2024) Vol. 130, Iss. 17, pp. 2918-2927
Closed Access | Times Cited: 6
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 6
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 6
Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
Shiwei Yue, Yunpu Zhang, Wei Zhang
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1089-1111
Open Access | Times Cited: 6
Shiwei Yue, Yunpu Zhang, Wei Zhang
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1089-1111
Open Access | Times Cited: 6
EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer and their prognostic significance
Yeseul Kim, Seungyun Jee, Hyunsung Kim, et al.
The Oncologist (2024)
Open Access | Times Cited: 5
Yeseul Kim, Seungyun Jee, Hyunsung Kim, et al.
The Oncologist (2024)
Open Access | Times Cited: 5
Current biologics for treatment of biliary tract cancers
Diana Yi Zhao, Kian‐Huat Lim
Journal of Gastrointestinal Oncology (2017) Vol. 8, Iss. 3, pp. 430-440
Open Access | Times Cited: 41
Diana Yi Zhao, Kian‐Huat Lim
Journal of Gastrointestinal Oncology (2017) Vol. 8, Iss. 3, pp. 430-440
Open Access | Times Cited: 41
Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition
Dustin J. Flanagan, Simon A. Woodcock, Caroline Phillips, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108179-108179
Open Access | Times Cited: 22
Dustin J. Flanagan, Simon A. Woodcock, Caroline Phillips, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108179-108179
Open Access | Times Cited: 22
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
Davide Ciardiello, Brigida Anna Maiorano, Paola Parente, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 820-820
Open Access | Times Cited: 21
Davide Ciardiello, Brigida Anna Maiorano, Paola Parente, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 820-820
Open Access | Times Cited: 21
Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients
Tessa J. J. de Bitter, Philip R. de Reuver, Elise A. J. de Savornin Lohman, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 21
Tessa J. J. de Bitter, Philip R. de Reuver, Elise A. J. de Savornin Lohman, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 21
NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study
Sonja Boyd, Taru Mustamäki, Nelli Sjöblom, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 4
Sonja Boyd, Taru Mustamäki, Nelli Sjöblom, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 4
Surgical management of intrahepatic cholangiocarcinoma
D. Brock Hewitt, Zachary J. Brown, Timothy M. Pawlik
Expert Review of Anticancer Therapy (2021) Vol. 22, Iss. 1, pp. 27-38
Open Access | Times Cited: 27
D. Brock Hewitt, Zachary J. Brown, Timothy M. Pawlik
Expert Review of Anticancer Therapy (2021) Vol. 22, Iss. 1, pp. 27-38
Open Access | Times Cited: 27
Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma
Fanli Zeng, Jing-fang Chen
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 26
Fanli Zeng, Jing-fang Chen
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 26
IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100356-100356
Open Access | Times Cited: 25
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100356-100356
Open Access | Times Cited: 25
Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022
Zishuo Ian Hu, Kian‐Huat Lim
Cancers (2022) Vol. 14, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 17
Zishuo Ian Hu, Kian‐Huat Lim
Cancers (2022) Vol. 14, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 17
Precision Oncology Targets in Biliary Tract Cancer
Nicole Farha, Danai Dima, Fauzia Ullah, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2105-2105
Open Access | Times Cited: 10
Nicole Farha, Danai Dima, Fauzia Ullah, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2105-2105
Open Access | Times Cited: 10
Own experience of using anti-HER2 therapy for cancer of the intrahepatic cholangiocarcinoma
P. V. Golubev, E. S. Kuzmina, И. А. Покатаев, et al.
Medical alphabet (2025), Iss. 32, pp. 14-18
Closed Access
P. V. Golubev, E. S. Kuzmina, И. А. Покатаев, et al.
Medical alphabet (2025), Iss. 32, pp. 14-18
Closed Access
Recent progress in emerging molecular targeted therapies for intrahepatic cholangiocarcinoma
Younghoon Kim, Jaewon Song, Namkyoung Kim, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Younghoon Kim, Jaewon Song, Namkyoung Kim, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics
Xiaoqiang Cui, Teng Huang, Tianyi Jiang, et al.
Cancer Letters (2025) Vol. 614, pp. 217540-217540
Closed Access
Xiaoqiang Cui, Teng Huang, Tianyi Jiang, et al.
Cancer Letters (2025) Vol. 614, pp. 217540-217540
Closed Access
Cholangiocarcinoma: The era of liquid biopsy
Evgenia Kotsifa, Francesca Saffioti, Vasileios Mavroeidis
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access
Evgenia Kotsifa, Francesca Saffioti, Vasileios Mavroeidis
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access
